Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
NeuroVive Initiates Collaboration With Leading US TBI Research Organization
2018-05-02 15:24
Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
2018-04-27 20:38
Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
2018-04-27 18:48
NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference
2018-04-20 18:52
NeuroVive's Board Members, Senior Executives and Employees Will Subscribe Units in the Ongoing Rights Issue
2018-04-20 15:21
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases
2018-04-18 15:57
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
2018-04-17 15:03
NeuroVive Pharmaceutical AB Year End Report January - December 2017
2018-02-20 16:05
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
2018-02-15 16:35
NeuroVive Decides on a Rights Issue for Continued Drug Development
2018-02-15 16:18
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project
2018-01-29 21:05
NeuroVive to Present at the 10th Annual Biotech Showcase Conference
2018-01-03 16:10
NeuroVive's KL1333 Program Granted Orphan Drug Designation by the European Commission
2017-12-13 16:11
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333
2017-12-11 18:56
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)
2017-11-30 19:51
NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone
2017-11-30 16:26
NeuroVive Pharmaceutical AB Interim Report January - September 2017
2017-11-21 15:56
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference
2017-11-15 16:48
NeuroVive Board Chair Resigns, New Chair Elected
2017-11-07 15:55
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million
2017-11-03 16:33
1
2
3
4